Pharmabiz2h
Hutchmed begins phase I trial of menin inhibitor HMPL-506 in patients with haematological malignancies in China
Hutchmed (China) Limited announces that it has initiated phase I clinical trial of its menin inhibitor HMPL-506 in patients with haematological malignancies in China. The first patient received their ...
Pharmabiz3h
CordenPharma and Certest ink partnership on ionizable lipids in LNP formulation
CordenPharma, a global CDMO leader in the manufacture of drug substances (APIs) for complex modalities, LNPs containing xRNA/xDNA, and injectable drug products, and Certest, a Spanish company focused ...
Pharmabiz5h
US FDA grants fast-track designation to EnGeneIC’s ANDC pancreatic cancer therapeutic
EnGeneIC, an innovative biopharmaceutical company leading the field of armed antibody therapeutics for oncology, has achieved a significant milestone with the granting of FDA “Fast-Track” designation ...
Pharmabiz12h
APTI & other associations in Odisha to demand to the new state govt to unveil pharma industry-friendly policy
With the collective support of all pharmacy professional associations in Odisha, the state branch of the Association of Pharmacy Teachers of India (APTI) is taking an initiative to demand to the ...
Pharmabiz12h
SMPMA urges DCGI to allow manufacturing of multivitamins under food supplements category
The Small and Medium Pharma Manufacturers Association (SMPMA) has urged the Drug Controller General of India (DCGI) to include SMPMA in Consultative Committees and resolution of licensing issues in ...
Pharmabiz10h
Atriva gets US patent for MEK inhibitor zapnometinib, a first-in-class broad spectrum therapy for severe RNA virus infections including bird flu
Martinsried, Germany Monday, June 10, 2024, 16:00 Hrs [IST] ...
Pharmabiz12h
FDI equity inflow into pharma sector declines 48 per cent in FY24
The Foreign Direct Investment (FDI) equity inflow into the pharmaceutical sector has reported a decline of 48.3 per cent during the fiscal 2023-24, after a 45.5 per cent growth reported in the ...
Pharmabiz12h
IP Alliance opposes India's continued placement on USTR’s Priority Watch List
In response to India being placed on the Priority Watch List in the United States Trade Representative (USTR) 2024 Special 301 Report, the Indian Pharmaceutical Alliance (IP Alliance), an alliance of ...
Pharmabiz12h
KADMA urges Union govt to reduce ABS percentage
The Karnataka Ayush Drug Manufacturers Association (KADMA) is now accelerating the pace of support to the industry by representing its issues across to the central and state governments. This includes ...
Pharmabiz13h
US FDA approves Geron’s Rytelo to treat adult patients with lower-risk MDS with transfusion-dependent anaemia
Foster City, California Monday, June 10, 2024, 13:00 Hrs [IST] ...
Pharmabiz9h
AbbVie employees in Mumbai volunteer during 9th Annual ‘Week of Possibilities’ to support young adults with cerebral palsy
AbbVie, a global biopharmaceutical company focused on creating innovative medicines and solutions that address complex health issues and enhance people's lives, announced the ninth annual ‘Week of ...
Pharmabiz12h
Schneider Electric unveils EcoStruxure for life science segment to propel sustainability in Indian pharma
Schneider Electric unveils EcoStruxure for life science segment to propel sustainability in Indian pharma: Our Bureau, Bengaluru Monday, June 10, 2024, 14:15 Hrs [IST] Schneider E ...